oral glp-1 agonist approved Not an April fool's prank! The small molecule receptor agonist, orforglipron, has been by the FDA under the trade name, "Foundayo." We discussed the data in a fall 2025 episode Oral Semaglutide Approved to Reduce

The specific dosages studied in many of these animal models are very high when extrapolated to human equivalent doses

Some researchers might push this to 6 weeks, but we recommend exercising extreme caution beyond the 4-week mark to ensure optimal efficacy

A., & Huijbregts, P

Because theyre not regulated by the FDA, check that the peptide powder has been tested to be pure by an independent laboratory such as NSF or USP

Produced in European, GMP state-of-the-art laboratories, our peptides are trusted for scientific research and development

High concentration of glucose in DKD induces apoptosis of podocytes, glomerular endothelial cells, and so on, leading to tubulointerstitial fibrosis and glomerulosclerosis (Zheng et al., 2021)